From: Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
Responses
No. of patients
%
Complete response
2
5
Partial response
13
32
Stable disease
17
41
Progressive disease
9
22
Clinical Benefit
78